Scaling access to innovations for HIV prevention

Andrea Nannipieri • 2 August 2022

When the global HIV epidemic began more than 40 years ago, HIV was a terminal illness. It’s now a preventable and chronic disease for people who are able to access treatment. However, access to prevention and treatment services is not equitable, and new innovations are not always reaching people in need.

It has been more than a decade since the first evidence of the efficacy of daily oral pre-exposure prophylaxis (PrEP) was published. PrEP is a daily pill you can take that helps prevent HIV. In 2021, more than 1.6 million people worldwide were receiving oral pre- exposure prophylaxis (PrEP), which remains well short of the 2025 target of 10 million people.

Read more here

Back to the UNDP at AIDS 2022 landing page

Be the first one to comment


Please log in or sign up to comment.